This pathology is characterized by mutations of the gene that encodes the WAS protein (WASp), and is characterized by immunodeficiency, thrombocytopenia, and eczema among others, and an increased risk to develop autoimmune disorders and malignancies, such as lymphoma. This evidence concerns the gene WAS and immune system disorder.